No Data
Praxis Precision Med Price Target Maintained With a $270.00/Share by Piper Sandler
Piper Sandler Initiates a Buy Rating on Praxis Precision Medicines (PRAX)
Value Of Praxis Precision Medicines' Lead Program In Essential Tremor Alone Is Underappreciated: Analyst
Needham Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $145
Needham analyst Ami Fadia initiates coverage on $Praxis Precision Medicines(PRAX.US)$ with a buy rating, and sets the target price at $145.According to TipRanks data, the analyst has a success rate of
Praxis Precision Med Initiated at Buy by Needham
Express News | Praxis Precision Medicines Inc : Needham Initiates Coverage With Buy Rating; Price Target $145